KQEH Nightly Business Report October 30, 2015
The day. The potential tieup is a complicated one, and it puts pfizer in a familiar position. Last year it unsuccessfully pursued astra zeneca, but as meg tirrell reports it now hopes for a different outcome. Reporter pfizer confirmed today its in friendly discussions about a potential combination with irish drug company allergan, the maker of botox. Analysts expect the deal value could total 150 billion. This comes a year and a half after pfizer abandoned its 120 billion bid for astrazeneca. After the british drugmaker resisted its advances in a nasty monthlong battle. Many think allergan wil...